Digoxin Injection
Product Images NDC 0404-9850

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Digoxin (NDC 0404-9850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Chemical structure of Digoxin showing its steroid nucleus, sugar moieties, and characteristic hydroxyl and lactone groups, consistent with the active ingredient in this labeled product.*

FDA Label Image

Image1.jpg (Image1)

A table titled 'Recommended Digoxin Injection Loading Dose' listing total IV loading doses in micrograms per kilogram (mcg/kg) for adult patients. The table indicates an initial administration of half the total loading dose, followed by one-quarter of the dose every 6-8 hours twice. The recommended total IV loading dose range for adults is 8-12 mcg/kg. An explanatory note defines mcg as microgram.*

FDA Label Image

Image2.jpg (Image2)

A data table titled 'Recommended Starting Digoxin Injection Maintenance Dosage in Adult Patients' showing the total intravenous maintenance dose in micrograms per kilogram per day (mcg/kg/day) for adult patients, with a dose range of 2.4-3.6 mcg/kg/day given once daily. The table also includes a note defining mcg as microgram.*

FDA Label Image

Image3.jpg (Image3)

A data table titled "Recommended Maintenance Dose (in micrograms given once daily) of Digoxin Injection in Adult Patients by Lean Body Weight and by Renal Function." It presents corrected creatinine clearance rates, corresponding recommended digoxin doses by lean body weight (40 to 100 kg), and the number of days before steady state is achieved. Footnotes explain dose assumptions and creatinine clearance corrections.*

FDA Label Image

Image4.jpg (Image4)

A data table titled 'Comparison of the Systemic Availability and Equivalent Doses of Oral and Intravenous Digoxin.' It compares Digoxin tablets and Digoxin intravenous injection in terms of absolute bioavailability percentages and equivalent doses in micrograms (mcg).*

FDA Label Image

Image5.jpg (Image5)

A table presenting data on digoxin concentration changes due to drug interactions. It categorizes drugs by their impact: those increasing digoxin concentrations greater than 50%, less than 50%, and no significant changes. The table includes serum concentration increases, AUC increases, and dosing recommendations for monitoring and adjustment.*

FDA Label Image

Image6.jpg (Image6)

A drug information table listing drug classes, specific drugs, and their interactions or effects related to digoxin use. The table includes details on antiarrhythmics, parathyroid hormone analogs, thyroid supplements, sympathomimetics, neuromuscular blocking agents, supplements, and beta-adrenergic blockers, highlighting potential risks such as arrhythmias, sudden death, and electrolyte disturbances.*

FDA Label Image

Image8.jpg (Image8)

A table titled 'Times to Onset of Pharmacologic Effect and to Peak Effect of Preparations of Digoxin' comparing Digoxin tablets and Digoxin injection/IV. It lists onset times as 0.5-2 hours for tablets and 5-30 minutes for injection/IV, with peak effect times of 2-6 hours for tablets and 1-4 hours for injection/IV. Footnotes note effects documented for ventricular response rate and influence of infusion rate.*

FDA Label Image

Label1.jpg (Label1)

Label for Digoxin Injection USP, 0.5 mg/2 mL (250 mcg/mL) ampul for intravenous or intramuscular use. The label includes storage instructions, manufacturer Henry Schein, Inc. address, NDC 0404-9850, and directions for use without dilution. Also shows barcode, lot and expiration placeholders, and prescription use indication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.